GOLDEN, Colo.–Vitro Diagnostics, Inc. (OTCBB: VODG), dba Vitro Biopharma, announced the introduction of “Tools for Stem Cell and Drug Development™” at the recently held Society of Toxicology meeting in Baltimore, MD. These products are designed to support stem cell and cancer research specifically targeting mesenchymal stem cells (MSCs) and a new type of stem cell […]
ST. LOUIS and MOUNTAIN VIEW, Calif., March 31 — Sigma-Aldrich (Nasdaq: SIAL – News) today announced an agreement to supply high quality services and oligonucleotides to Gene Oracle, an innovative gene synthesis company. Under the terms of the agreement, Sigma-Aldrich will be the exclusive supplier of custom oligonucleotides for Gene Oracle, and the two Companies […]
ATHENS, Ga., March 31 — ArunA Biomedical, Inc., a leader in human embryonic stem cell derived products, announced today that it has co-developed a validated kit to produce induced pluripotent stem cells with Open Biosystems now part of Thermo Fisher. In the spirit of collaboration ArunA Biomedical and Open Biosystems will launch the complete and […]
LOGAN, Utah, (March 30, 2009) – Thermo Fisher Scientific Inc., the world leader in serving science, has expanded its stem cell research offering with the introduction of four new cell culture products: Thermo Scientific HyClone HyStem Hydrogels, HyStem Hydrogel, HyStem-C and HyStem-HP. Stem cells need to be cultured on uniquely designed surfaces for optimal proliferation […]
New England Peptide Names former rival and Global Peptide founder, John Phipps as West Coast Business Development Chief. Gardner, MA (PRWEB) March 30, 2009 — New England Peptide, LLC, (NEP) has named John Phipps, a leading peptide chemist and entrepreneur, to the new position of western region business development manager. In 2001, Phipps founded Global […]
– Extends Successful Existing Distribution Agreement for the Americas – – The Agreement for Europe Will Ensure Researchers Can Easily Access ZyGEM’s Growing Line of DNA Extraction Kits – – ZyGEM’s Technology Enables Lower-Cost DNA Extraction and Is Ideally Suited to Automation and High-Throughput Applications – SOLANA BEACH, Calif., and HAMILTON, New Zealand, March 26 […]
Horizon Discovery (Horizon) today announced it has secured world-wide exclusive rights to a panel of new patient-relevant human isogenic disease models developed by University of Maryland, Baltimore using its proprietary GENESIS platform. The in-licensed lines will be added to Horizon’s rapidly expanding number (150+) of X-MANTM (Mutant And Normal) cell models that allow drug discovery […]
– Stemgent to provide CellDesign’s proprietary adipocyte differentiation kits – SAN DIEGO and NEW HAVEN, Conn., March 24 — Stemgent has signed a co-exclusive license to market CellDesign’s AdipoDesign Starter Kit and AdipoDesign MaxiKit, which enable researchers to grow and study adipocytes from adipogenic progenitor cells. This agreement strengthens Stemgent’s position as a provider of […]
HEIDELBERG, Germany–Gene Bridges GmbH, the recombineering company, today announced that Daiichi Sankyo Co., Ltd. of Tokyo, Japan has completed a commercial license agreement for the use of the Red/ET recombination technology from Gene Bridges. The Red/ET recombination technology, patented in Japan under the title “Novel DNA Cloning Method“, is a valued method for generating targeting […]
ATHENS, Ga., March 23 — ArunA Biomedical, Inc., announced today an agreement with Neuromics, Inc. of Edina, MN, giving Neuromics the right to non-exclusively market and sell the ArunA hN2(TM) Human Neural Cells and Neural Culture Medium to support applications in neurological research. (Logo: https://www.newscom.com/cgi-bin/prnh/20080819/CLTU003LOGO ) ArunA has an exclusive worldwide license to develop and […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
